Texas Instruments Incorporated
TXN Technology · SemiconductorsDeep value.
Deep Value (Bullish) — Filing.fyi's reading derived from the latest 10-K and forensic scores.
The four readings.
What the filing actually says.
Texas Instruments’ 2025 10-K is notable for its explicit articulation of shareholder value creation, framing “the growth of free cash flow per share over the long term” as the “best metric for owners to measure our progress.” This objective, outlined in the MD&A, underpins a strategy built on “three elements,” including a business model focused on analog and embedded processing products. Free cash flow per share, defined as the cash generated after operating expenses and capital expenditures, divided by the number of outstanding shares, is presented as the ultimate measure of the company’s progress.
The forensic scores align with a picture of financial stability. Beneish’s 1999 eight-ratio earnings-manipulation detector registers -2.4546, comfortably below the -1.78 threshold that signals elevated risk. Similarly, Altman’s Z″ — a 1968 bankruptcy-distress index — stands at 10.01, placing the company well within the “safe” zone (above 2.60). The Piotroski F-Score, a 9-point fundamental strength scan, and the Fog Index, a readability score, are not available for this filing, leaving those specific analytical avenues unexplored.
The MD&A elaborates on a “great business model” built around “four sustainable competitive advantages,” including a strong foundation of manufacturing and technology that provides lower costs and greater control of our supply chain. This strategic emphasis on internal capabilities is presented as a tangible benefit, directly supporting the long-term free cash flow objective. While the Item 1A risk factors acknowledge susceptibility to “macroeconomic weakness,” the MD&A’s detailed strategic overview suggests a proactive approach to mitigating broader market volatility through operational control.
While the filing provides a clear view of management’s strategic priorities and current financial health indicators, it does not offer a definitive verdict on the security’s market valuation. The explicit focus on free cash flow per share provides a lens for evaluating management’s performance against its stated goals. However, external market conditions, competitive dynamics beyond the company’s control, and future technological shifts remain outside the scope of this document. The filing describes the company’s internal state; it does not predict the market’s response.
Filing timeline
- Feb 6, 202610-KAnnual report (2025-12-31)Period: 2025-12-310Read →
- Feb 6, 20268-KMaterial event (2026-02-03)No specific items found in 8-K.0Read →
- Feb 4, 20268-KMaterial event (2026-02-04)No specific items found in 8-K.0Read →
- Jan 27, 20268-KMaterial event (2026-01-27)No specific items found in 8-K.0Read →
- Oct 23, 202510-QQuarterly report (2025-09-30)Period: 2025-09-300Read →
- Mar 5, 2025DEF 14AProxy statement (2025-04-17)0Read →
If this case caught your eye
Financial Shenanigans
Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.
View on Amazon →The Interpretation of Financial Statements
The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.
View on Amazon →Quality of Earnings
Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.
View on Amazon →